Skip to main content

Table 1

From: Health-related quality of life (HRQoL) assessment with once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial

 

DRV/r 800/100mg qd (n=262)

DRV/r 600/100mg bid (n=268)

Mean (SE) change in total FAHI score from baseline (ITT-LOCF)

  

Baseline value

124.1 (1.78)

121.2 (1.73)

Week 4

0.4 (1.10)

1.3 (1.08)

Week 12

3.2 (1.18)

1.7 (1.28)

Week 24

2.8 (1.27)

2.5 (1.26)

Week 48

2.7 (1.36)

3.1 (1.40)

FAHI responders (LOCF) at Week 48, %

27.5

29.5